Nitric oxide synthase 2Lambaréné (G-954C), increased nitric oxide production, and protection against malaria

Journal of Infectious Diseases

Volumn 184, Issue 3, 2001, Pages 330-336

  Kun, Jürgen F ^a   Mordmüller, Benjamin ^a,f   Perkins, Douglas J ^a,b   May, Jürgen ^a   Mercereau Puijalon, Odile ^c   Alpers, Michael ^d   Weinberg, J Brice ^e   Kremsner, Peter G ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b ALBERT SCHWEITZER HOSPITAL   (Gabon)

^c INSTITUT PASTEUR   (France)

^d PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^e DURHAM VA MEDICAL CENTER   (United States)

^f MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ARTICLE; CHILD; CONTROLLED STUDY; ENDEMIC DISEASE; ENZYME ACTIVITY; FEMALE; GENETIC RESISTANCE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; SICKLE CELL TRAIT;

CASE-CONTROL STUDIES; CHILD; DNA; FEMALE; GABON; GENE FREQUENCY; GERMANY; HETEROZYGOTE DETECTION; HUMANS; IMMUNITY, NATURAL; MALARIA; MALE; NIGERIA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PAPUA NEW GUINEA; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; SENEGAL; THAILAND;

EID: 0035426161     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/322037     Document Type: Article

References (37)

1. Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population
2. The treatment of malaria
3. Malaria's Eve: Evidence of a recent population bottleneck throughout the world populations of Plasmodium falciparum
4. Protection afforded by sickle cell trait against subtertian malarial infection
5. A polymorphism that affects OCT1 binding to the TNF promoter region is associated with severe malaria
6. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria
7. Mannose-binding lectin plasma levels and gene polymorphisms in Plasmodium falciparum malaria
8. Common West African HLA antigens are associated with protection from severe malaria
9. Ovalocytosis and cerebral malaria
10. High incidence of malaria in α-thalassaemic children
11. Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria
12. The role of red blood cell polymorphisms in resistance and susceptibility to malaria
13. Hemoglobin C associated with protection from severe malaria in the Dogon of Mali, a West African population with a low prevalence of hemoglobin S
14. Nitric oxide expression in the spleen, but not in the liver, correlates with resistance to blood-stage malaria in mice
15. IFN-γ inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism
16. L-arginine-dependent destruction of intrahepatic malaria parasites in response to tumor necrosis factor and/or interleukin 6 stimulation
17. Killing of Plasmodium falciparum in vitro by nitric oxide derivatives
18. The role of TH1 and TH2 cells in a rodent malaria infection
19. Enhanced production of reactive nitrogen intermediates in human and murine malaria
20. Inducible nitric oxide synthase: What difference does it make?
21. Interferon-γ induced lethality in the late phase of Plasmodium vinckei malaria despite effective parasite clearance by chloroquine
22. High plasma levels of nitrogen oxides are associated with severe disease and correlate with rapid parasitological and clinical cure in Plasmodium falciparum malaria
23. Nitric oxide in Tanzanian children with malaria: Inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression
24. Polymorphism in the promoter region of the inducible nitric oxide synthase gene and protection against malaria
25. Merozoite surface antigen 1 and 2 genotyping and rosetting of Plasmodium falciparum in severe versus mild malaria in Lambaréné, Gabon
26. A comparative trial of three regimens for treating uncomplicated falciparum malaria in Acre, Brazil
27. Malaria pigment in leucocytes
28. Quinine plus clindamycin improves chemotherapy of severe malaria in children
29. Pyrimethamine/sulfadoxine for treating uncomplicated Plasmodium falciparum malaria in young children in Gabon
30. Blood mononuclear cell nitric oxide production and plasma cytokine levels in healthy Gabonese children with prior mild or severe malaria
31. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: Increased nitric oxide production and nitric oxide synthase expression in MRL-1pr/1pr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine
32. No influence of socioeconomic factors on severe malarial anaemia, hyperparasitaemia or reinfection
33. Plasmodium falciparum transmission intensity and infection rates in children in Gabon
34. Nitric oxide synthase type 2 promoter polymorphisms, nitric oxide production, and disease severity in Tanzanian children with malaria
35. Inducible nitric oxide synthase polymorphism and fatal cerebral malaria